切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2018, Vol. 07 ›› Issue (01) : 52 -56. doi: 10.3877/cma.j.issn.2095-3224.2018.01.011

所属专题: 文献

论著

结肠癌患者SIRT6表达与病理特征的相关性
耿长辉1,(), 张春玲2, 曹珍珍3, 衣洪天1, 何苗4, 黄树民5, 菅晶晶1, 高萍5   
  1. 1. 163001 大庆,哈尔滨医科大学附属第五医院普外科
    2. 163001 大庆油田总医院超声医学科
    3. 163001 大庆,哈尔滨医科大学附属第五医院检验科
    4. 163001 大庆油田总医院病理科
    5. 163001 大庆油田总医院消化内科
  • 收稿日期:2017-07-19 出版日期:2018-02-25
  • 通信作者: 耿长辉
  • 基金资助:
    大庆市指导性科技项目计划(No. ZDY-2016-029)

The correlation between SIRT6 expression and pathological features in patients with colon cancer

Changhui Geng1,(), ChunLing Zhang2, Zhenzhen Cao3, Hongtian Yi1, Miao He4, Shumin Huang5, Jingjing Jian1, Ping Gao5   

  1. 1. Department of General Surgery, the Fifth Affiliated Hospital of Harbin Medical University, Daqing 163001, China
    2. Department of Ultrasound, Daqing Oilfield General Hospital, Daqing 163001, China
    3. Department of Cinical Laboratory, the Fifth Affiliated Hospital of Harbin Medical University, Daqing 163001, China
    4. Department of Pathology, Daqing Oil Field General Hospital, Daqing 163001, China
    5. Department of Gastroenterology, Daqing Oil Field General Hospital, Daqing 163001, China
  • Received:2017-07-19 Published:2018-02-25
  • Corresponding author: Changhui Geng
  • About author:
    Corresponding author: Geng Changhui, Email:
引用本文:

耿长辉, 张春玲, 曹珍珍, 衣洪天, 何苗, 黄树民, 菅晶晶, 高萍. 结肠癌患者SIRT6表达与病理特征的相关性[J]. 中华结直肠疾病电子杂志, 2018, 07(01): 52-56.

Changhui Geng, ChunLing Zhang, Zhenzhen Cao, Hongtian Yi, Miao He, Shumin Huang, Jingjing Jian, Ping Gao. The correlation between SIRT6 expression and pathological features in patients with colon cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2018, 07(01): 52-56.

目的

研究结肠癌患者SIRT6表达与病理特征的相关性及其可能的机制。

方法

纳入2015年4月至2017年4月哈尔滨医科大学附属第五医院普外科60例结肠癌患者作为研究对象,所有患者均取手术切除的结肠癌组织和癌旁正常结肠组织作为病检标本,采用Western blot法和免疫组化法检测SIRT6蛋白和HIF-1α表达水平,收集60例患者性别、年龄、肿瘤TNM分期、分化等临床病理特征,记录结肠癌和癌旁组织中SIRT6和HIF-1α水平,比较SIRT6不同表达水平病理特征的差异,分析SIRT6与病理特征和HIF-1α的关系。

结果

Western blot法检测的结肠癌组织中SIRT6和HIF-1α蛋白表达分别为(1.87±0.65)和(1.72±0.59),癌旁组织中SIRT6和HIF-1α分别为(2.34±1.13)和(0.84±0.36),结肠癌组织和癌旁组织中SIRT6和HIF-1α表达水平差异有统计学意义(t=2.793,9.862;P=0.006,0.000)。60例患者中结肠癌组织中SIRT6蛋白阳性13例,阴性47例。Logistic多因素分析显示肿瘤分期是影响结肠癌患者癌组织中SIRT6蛋白高表达水平的独立因素(OR=0.335;P=0.000)。结肠癌组织中SIRT6蛋白表达与HIF-1α水平呈显著负相关性(r=-0.819,P=0.000)。

结论

结肠癌组织中SIRT6蛋白表达水平与肿瘤分期关系密切,SIRT6蛋白对结肠癌病理进程有抑制作用,这可能与SIRT6调控HIF-1α蛋白有关。

Objective

To study the correlation between SIRT6 expression and pathological features in patients with colon cancer and its possible mechanism.

Methods

Sixty patients with colon cancer from April 2015 to April 2017 in Department of General Surgery, Fifth Affiliated Hospital of Harbin Medical University were included in this study, all colon cancer tissues and para cancerous normal colon tissues by surgical excision were taken as pathological specimens.The expression levels of SIRT6 protein and HIF-1α were detected by Western blot method and immunohistochemical method.The clinical and pathological characteristics of gender, age, tumor TNM stage and differentiation in 60 patients were collected. The levels of SIRT6 and HIF-1α in colon cancer and paracancerous tissues were recorded. The difference of pathological features of SIRT6 with different expression levels were compared. The relationship between SIRT6 and pathological features and HIF-1α were analyzed.

Results

The protein expressions of SIRT6 and HIF-1α in colon cancer tissues by western blot were (1.87±0.65) and (1.72±0.59), the levels of SIRT6 and HIF-1α in the para cancerous normal colon tissues were (2.34±1.13) and (0.84±0.36). There were significant difference of the expression of SIRT6 and HIF-1α between colon cancer tissues and the para cancerous normal colon tissues (t=2.793, 9.862; P=0.006, 0.000).The positive SIRT6 protein were 13 cases and the negative were 47 cases among the 60 patients.The logistic multivariate analysis showed that tumor staging was the independent factor, which affected the high expression of SIRT6 protein in colon cancer tissues (OR=0.335; P=0.000). The expression of SIRT6 protein was negatively correlated with the level of HIF-1α in colon cancer tissues (r=-0.819, P=0.000).

Conclusion

The expression of SIRT6 protein in colon cancer tissues are closely related to tumor staging.The SIRT6 protein may inhibit the pathological process of colon cancer, which may be related to the regulation of HIF-1α by SIRT6.

图4 HIF-1α在结肠癌和癌旁组织中表达
表1 不同病理特征患者SIRT6表达差异(例,%)
图6 SIRT6在结肠癌癌旁组织中阳性表达(×10)
表2 SIRT6蛋白表达多因素分析
图7 SIRT6和HIF-1α相关性分析
[1]
刘清华,陈依红.结肠癌根治术后5年无病生存率影响因素分析 [J]. 结直肠肛门外科, 2017, 23(1): 27-31.
[2]
Ueno T, Endo S, Saito R, et al. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells [J]. Oncology Research, 2013, 21(3): 155.
[3]
陶娜娜,周洪钟,任吉华, 等.Sirtuin 6对肝癌细胞增殖的影响 [J]. 中国病理生理杂志, 2016, 32(6): 1031-1036.
[4]
张子杰.结肠癌组织VEGF表达与树突状细胞浸润的临床意义及与血清VEGF浓度及其活化水平的相关性 [J]. 中国免疫学杂志, 2015, 31(9): 1257-1261.
[5]
张玥,石菊芳,黄慧瑶, 等.中国人群结直肠癌疾病负担分析 [J]. 中华流行病学杂志, 2015, 36(7): 709-714.
[6]
卢灿荣,张士武,张勇, 等.联合检测癌胚抗原、糖链抗原19-9和C反应蛋白对结肠癌的诊断价值 [J]. 标记免疫分析与临床, 2012, 19(1): 3-6.
[7]
陈伟,王贵玉,陈瑛罡, 等.1810例左、右半结肠癌临床病理分析 [J]. 中华结直肠疾病电子杂志, 2013, 2(4): 162-165.
[8]
Banday MZ, Sameer AS, Mir AH, et al. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population -- A case–control study and a mini review [J]. Gene, 2016, 589(1): 81-89.
[9]
Bakiri L. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin [J]. Nature Cell Biology, 2012, 14(11): 1203.
[10]
Rizzo A, Iachettini S, Salvati E, et al. SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage [J]. Nucleic Acids Research, 2016, 45(4): 1820.
[11]
井浩人,周毅.miR-33a通过抑制SIRT6的表达促进结直肠癌细胞的增殖 [J]. 临床医学研究与实践, 2017, 2(25): 5-8.
[12]
周玥,王亚平,王建伟, 等.三丁基过氧化氢体外诱导造血干/祖细胞衰老中的SIRT6/NF-κB信号轴 [J]. 中国组织工程研究, 2014, 18(37): 5967-5971.
[13]
齐佳,崔春晖,陈日红, 等.SIRT6在结直肠癌组织中的表达及其临床意义 [J]. 安徽医科大学学报, 2017, 52(2): 281-285.
[14]
来伟,施景龙,林显敢, 等.肿瘤抑制基因N-myc下游调节基因2调节结肠癌细胞糖代谢 [J]. 中华实验外科杂志, 2016, 33(11): 2533-2534.
[15]
蒲诗云,邝江莹,何金汗.SIRT6在能量代谢中的作用 [J]. 生理科学进展, 2014, 45(6): 448-452.
[16]
Prigione A, Rohwer N, Hoffmann S, et al. HIF1 modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2. [J]. Stem Cells, 2014, 32(2): 364.
[17]
Liu C, Huang Z, Jiang H, et al. The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients [J]. Biomed Research International, 2014, 2014(5795): 871263.
[18]
董振,雷倩,刘力超, 等.长寿蛋白SIRT6在肿瘤发生发展中的作用 [J]. 生物工程学报, 2016, 32(7): 870-879.
[1] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[2] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[3] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[4] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[5] 燕速, 霍博文, 徐惠宁. 4K荧光腹腔镜扩大右半结肠CME+D3根治术及No.206、No.204组淋巴结清扫术[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 14-14.
[6] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[7] 高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[8] 李晓晖, 上官昌盛, 向英, 裴芝皆, 车俊志, 谢飞. 3D腹腔镜袖状胃切除术后机体能量代谢与多囊卵巢综合征患者性激素水平关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 538-541.
[9] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[10] 侯文运, 刘恒昌, 窦利州, 陈海鹏, 郑朝旭, 王贵齐, 王锡山. 腹部无辅助切口内镜引导下取标本的腹腔镜辅助右半结肠癌根治术(保留回盲部)(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 436-440.
[11] 唐新, 刁德昌, 廖伟林, 林佳鑫, 汪佳豪, 李文娟, 谢嘉欣, 敖琳, 李洪明, 易小江, 卢新泉, 冯晓创. 保留神经的鞘外游离技术在腹腔镜右半结肠癌D3根治术中的近远期疗效分析:基于倾向性评分匹配的回顾性队列研究[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 372-380.
[12] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[13] 潘春江, 李科, 李新楼, 杨博, 任雪玲. 高龄老人骨转换代谢标志物与肾功能的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(05): 260-264.
[14] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[15] 魏红涛, 普布仓决, 格桑央宗, 黎燕, 益西旺扎, 李鹏. 拉萨地区上消化道溃疡患者幽门螺杆菌感染及治疗分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 662-665.
阅读次数
全文


摘要